Animal health product developer Bactana is advancing Cornell University research into probiotics that could lead to improved vitality for livestock including cattle, swine and poultry.

Rasu Shrestha, who had been UPMC's chief innovation officer since 2014, has taken on chief strategy officer and executive vice-president positions at peer Atrium Health.

VetMedUni biopharmaceutical spinout Marinomed Biotech has secured a $3.4m payment from a strategic tie-up with Link Health Pharma, after pausing its IPO process in November 2018.

Wren Therapeutics is commercialising Cambridge and Lund research into therapies for protein misfolding diseases, which include Alzheimer's and motor neurone disease.

Aptus-backed neurodegenerative-focused company Alzheon has withdrawn its second attempt at initial public offering, less than year after cancelling its first bid.

GV-backed care management platform Aledade has closed its latest round at nearly $56.2m after raising a second extension that followed two tranches of $23m each in 2017 and 2018.

Rob Lavine, News editor for Global Corporate Venturing, reviews the trends in venturing from 2018

The LivaNova-backed mitral valve replacement system developer has collected $36.3m in a round that increased its funding to almost $57m altogether.

Microsoft’s M12 subsidiary led an extension that brought Innovaccer’s series B round to a $35m close, and the company’s overall funding to $51m.

Formerly known as JustRight, Bolder has raised fresh funding in a Providence Ventures-backed round and rebranded to expand beyond paediatric equipment.